Sermorelin Reconstitution Guide
Part of the full Sermorelin guide - a growth hormone-releasing hormone reference compound, identity-verified with a COA on every vial.
In brief
Laboratory reconstitution of lyophilized Sermorelin for in-vitro work follows the standard principles for synthetic peptides: a defined diluent, a deliberate concentration calculation anchored to the molecular weight, and cold-chain handling that respects the molecule's known metabolic lability. This spoke describes preparation for bench and cell-culture research only, not any human dosing protocol. Sermorelin's average molecular weight of 3357.93 g/mol (free base) and its molecular formula C149H246N44O42S provide the quantitative basis for converting a target molar concentration into a mass, and for back-calculating the molarity of a stock solution once a known mass of peptide is dissolved in a measured diluent volume. Because the data identifies the peptide as rapidly cleaved by dipeptidyl peptidase-IV and short-lived in plasma, careful aliquoting and storage are emphasized to limit freeze-thaw exposure of reconstituted material. The steps below outline a generic, lab-scale reconstitution workflow grounded in these molecular parameters.
The detail
A closer look
01
Reconstitution principle and diluent
For in-vitro handling, lyophilized peptide is typically reconstituted in bacteriostatic water (water containing a small percentage of benzyl alcohol) for laboratory stock preparation, with the diluent added slowly down the vial wall rather than directed forcefully onto the peptide cake to minimize mechanical and foaming stress. The goal is a clear, fully dissolved stock from which working dilutions are made into the appropriate assay buffer or culture medium. Because Sermorelin carries an amidated C-terminus and a DPP-IV-labile Tyr1-Ala2 bond, gentle handling and prompt cold storage of the reconstituted stock are prudent. This is strictly a laboratory preparation step; concentrations described here serve in-vitro calculation, not administration.
02
Concentration calculation from molecular weight
Stock molarity is derived from the known mass of peptide and the diluent volume using the average molecular weight of 3357.93 g/mol. As a worked illustration, dissolving 1 mg of Sermorelin in 1 mL of bacteriostatic water yields a 1 mg/mL stock; dividing 1 mg/mL by 3357.93 g/mol gives approximately 0.298 mmol/L, i.e. roughly 298 micromolar. Halving the concentration to 0.5 mg/mL (2 mg in 4 mL, for example) yields about 149 micromolar. Researchers scale the diluent volume to hit a target stock concentration, then dilute further into assay buffer for the desired final treatment molarity. Anchoring every calculation to the 3357.93 g/mol figure keeps molar conversions internally consistent across experiments.
03
Storage and stability handling
Reconstituted peptide is handled cold and aliquoted to avoid repeated freeze-thaw cycles, which degrade peptide integrity. Given the molecule's documented metabolic lability, DPP-IV cleavage at the Tyr1-Ala2 bond and a short plasma half-life on the order of minutes, the in-vitro emphasis is on minimizing time at ambient temperature, protecting stock from unnecessary light and agitation, and keeping single-use aliquots so that working material is not subjected to multiple thaw events. Lyophilized, unopened material is generally the most stable form; reconstituted stock is the more labile state and is treated accordingly.
Step by step
How Sermorelin is reconstituted
A bench reference for handling and preparation in an in-vitro research setting. Not a personal dosing protocol.
- 1
Equilibrate the sealed lyophilized vial and the bacteriostatic-water diluent to room temperature before opening, to reduce condensation on the peptide cake.
- 2
Calculate the diluent volume needed for your target stock concentration using the 3357.93 g/mol average molecular weight (e.g., 1 mg in 1 mL gives 1 mg/mL, approximately 298 micromolar).
- 3
Draw the calculated volume of bacteriostatic water and add it slowly down the inner wall of the vial, letting it run onto the peptide rather than directing the stream onto the cake.
- 4
Do not shake; swirl gently or let the vial stand until the peptide fully dissolves into a clear solution.
- 5
Verify a clear, particle-free stock; record the exact mass, diluent volume, and resulting molar concentration in the lab notebook.
- 6
Prepare single-use aliquots to avoid repeated freeze-thaw cycles of the stock.
- 7
Store reconstituted stock cold and protected from light; keep unused lyophilized material sealed as the more stable reserve form.
- 8
Dilute aliquots into the appropriate assay buffer or culture medium to reach the final in-vitro treatment concentration immediately before use.
The fine print: products are sold for laboratory research use only and are not for human or animal consumption. Bodily introduction into humans or animals is strictly prohibited by law. Sermorelin is not a drug and is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA.